Literature DB >> 29914582

Importance of case age in the purported association between phylogenetics and hemolytic uremic syndrome in Escherichia coli O157:H7 infections.

G A M Tarr1, S Shringi2, H N Oltean3, J Mayer4, P Rabinowitz5, J Wakefield6, P I Tarr7, T E Besser2, A I Phipps4.   

Abstract

Escherichia coli O157:H7 is the largest cause of hemolytic uremic syndrome (HUS). Previous studies proposed that HUS risk varies across the E. coli O157:H7 phylogenetic tree (hypervirulent clade 8), but the role of age in the association is unknown. We determined phylogenetic lineage of E. coli O157:H7 isolates from 1160 culture-confirmed E. coli O157:H7 cases reported in Washington State, 2004-2015. Using generalised estimating equations, we tested the association between phylogenetic lineage and HUS. Age was evaluated as an effect modifier. Among 1082 E. coli O157:H7 cases with both phylogenetic lineage and HUS status (HUS n = 76), stratified analysis suggested effect modification by age. Lineages IIa and IIb, relative to Ib, did not appear associated with HUS in children 0-9-years-old. For cases 10-59-years-old, lineages IIa and IIb appeared to confer increased risk of HUS, relative to lineage Ib. The association reversed in ⩾60-year-olds. Results were similar for clade 8. Phylogenetic lineage appears to be associated with HUS risk only among those ⩾10-years-old. Among children <10, the age group most frequently affected, lineage does not explain progression to HUS. However, lineage frequency varied across age groups, suggesting differences in exposure and/or early disease manifestation.

Entities:  

Keywords:  Epidemiology; Escherichia coli (E. coli); Shiga toxin-producing E. coli; phylogenetics

Mesh:

Year:  2018        PMID: 29914582      PMCID: PMC6092231          DOI: 10.1017/S0950268818001632

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  34 in total

1.  Subtyping method for Escherichia coli shiga toxin (verocytotoxin) 2 variants and correlations to clinical manifestations.

Authors:  Søren Persson; Katharina E P Olsen; Steen Ethelberg; Flemming Scheutz
Journal:  J Clin Microbiol       Date:  2007-04-19       Impact factor: 5.948

2.  Variation in virulence among clades of Escherichia coli O157:H7 associated with disease outbreaks.

Authors:  Shannon D Manning; Alifiya S Motiwala; A Cody Springman; Weihong Qi; David W Lacher; Lindsey M Ouellette; Janice M Mladonicky; Patricia Somsel; James T Rudrik; Stephen E Dietrich; Wei Zhang; Bala Swaminathan; David Alland; Thomas S Whittam
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-10       Impact factor: 11.205

3.  ABO and P1 blood group antigen expression and stx genotype and outcome of childhood Escherichia coli O157:H7 infections.

Authors:  Srdjan Jelacic; Cheryl L Wobbe; Daniel R Boster; Marcia A Ciol; Sandra L Watkins; Phillip I Tarr; Ann E Stapleton
Journal:  J Infect Dis       Date:  2002-01-03       Impact factor: 5.226

Review 4.  Escherichia coli O157:H7 infection in nursing homes: review of literature and report of recent outbreak.

Authors:  Gary Reiss; Pamela Kunz; Diana Koin; Emmet B Keeffe
Journal:  J Am Geriatr Soc       Date:  2006-04       Impact factor: 5.562

5.  Clinical and microbiologic features of Shigella and enteroinvasive Escherichia coli infections detected by DNA hybridization.

Authors:  D N Taylor; P Echeverria; O Sethabutr; C Pitarangsi; U Leksomboon; N R Blacklow; B Rowe; R Gross; J Cross
Journal:  J Clin Microbiol       Date:  1988-07       Impact factor: 5.948

6.  Infections with Escherichia coli O157:H7 in Washington State. The first year of statewide disease surveillance.

Authors:  S M Ostroff; J M Kobayashi; J H Lewis
Journal:  JAMA       Date:  1989-07-21       Impact factor: 56.272

7.  Increased adherence and expression of virulence genes in a lineage of Escherichia coli O157:H7 commonly associated with human infections.

Authors:  Galeb S Abu-Ali; Lindsey M Ouellette; Scott T Henderson; David W Lacher; James T Riordan; Thomas S Whittam; Shannon D Manning
Journal:  PLoS One       Date:  2010-04-21       Impact factor: 3.240

8.  A population-based study of hemolytic-uremic syndrome in Oregon, 1979-1982.

Authors:  M F Rogers; G W Rutherford; S R Alexander; J H DiLiberti; L Foster; L B Schonberger; E S Hurwitz
Journal:  Am J Epidemiol       Date:  1986-01       Impact factor: 4.897

9.  Outbreaks of non-O157 Shiga toxin-producing Escherichia coli infection: USA.

Authors:  R E Luna-Gierke; P M Griffin; L H Gould; K Herman; C A Bopp; N Strockbine; R K Mody
Journal:  Epidemiol Infect       Date:  2014-01-07       Impact factor: 4.434

10.  Geogenomic Segregation and Temporal Trends of Human Pathogenic Escherichia coli O157:H7, Washington, USA, 2005-20141.

Authors:  Gillian A M Tarr; Smriti Shringi; Amanda I Phipps; Thomas E Besser; Jonathan Mayer; Hanna N Oltean; Jon Wakefield; Phillip I Tarr; Peter Rabinowitz
Journal:  Emerg Infect Dis       Date:  2018-01       Impact factor: 6.883

View more
  8 in total

Review 1.  Escherichia coli 0157:H7 virulence factors and the ruminant reservoir.

Authors:  Anna M Kolodziejek; Scott A Minnich; Carolyn J Hovde
Journal:  Curr Opin Infect Dis       Date:  2022-06-01       Impact factor: 4.968

Review 2.  Shiga Toxin-Associated Hemolytic Uremic Syndrome: Specificities of Adult Patients and Implications for Critical Care Management.

Authors:  Benoit Travert; Cédric Rafat; Patricia Mariani; Aurélie Cointe; Antoine Dossier; Paul Coppo; Adrien Joseph
Journal:  Toxins (Basel)       Date:  2021-04-26       Impact factor: 4.546

3.  Importance of case age in the purported association between phylogenetics and hemolytic uremic syndrome in Escherichia coli O157:H7 infections - ERRATUM.

Authors:  G A M Tarr; S Shringi; H N Oltean; J Mayer; P Rabinowitz; J Wakefield; P I Tarr; T E Besser; A I Phipps
Journal:  Epidemiol Infect       Date:  2019-10-21       Impact factor: 2.451

4.  Contribution and Interaction of Shiga Toxin Genes to Escherichia coli O157:H7 Virulence.

Authors:  Gillian A M Tarr; Taryn Stokowski; Smriti Shringi; Phillip I Tarr; Stephen B Freedman; Hanna N Oltean; Peter M Rabinowitz; Linda Chui
Journal:  Toxins (Basel)       Date:  2019-10-18       Impact factor: 4.546

5.  Association between Shiga Toxin-Producing Escherichia coli O157:H7 stx Gene Subtype and Disease Severity, England, 2009-2019.

Authors:  Lisa Byrne; Natalie Adams; Claire Jenkins
Journal:  Emerg Infect Dis       Date:  2020-10       Impact factor: 6.883

6.  Antibiotic resistance and phylogenetic profiling of Escherichia coli from dairy farm soils; organic versus conventional systems.

Authors:  Omega Y Amoafo; Vanita Malekar; Eirian Jones; Stephen L W On
Journal:  Curr Res Microb Sci       Date:  2021-12-10

Review 7.  Escherichia coli Shiga Toxins and Gut Microbiota Interactions.

Authors:  Kyung-Soo Lee; Yu-Jin Jeong; Moo-Seung Lee
Journal:  Toxins (Basel)       Date:  2021-06-11       Impact factor: 4.546

8.  Epidemiology of Shiga Toxin-Producing Escherichia coli O157 in the Province of Alberta, Canada, 2009-2016.

Authors:  Luiz F Lisboa; Jonas Szelewicki; Alex Lin; Sarah Latonas; Vincent Li; Shuai Zhi; Brendon D Parsons; Byron Berenger; Sumana Fathima; Linda Chui
Journal:  Toxins (Basel)       Date:  2019-10-22       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.